Grade: Pharmaceutical Grade

Factory Location: quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Delgocitinib has inhibitory effects on JAK1, JAK2, JAK3 and tyrosine kinase 2. In preclinical studies, Chemicalbook, topical application of delgocitinib inhibits skin inflammation, improves skin barrier dysfunction, and suppresses itching induced by IL-31.